Global Exporter & Bulk Supplier: Crizlieva 250mg Tablet

🌍 Market Overview

Are you searching for a highly dependable international supply chain partner for advanced targeted oncology therapeutics?

Ernest Oncology (a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd.) operates as a premier global exporter, bulk supplier, and distributor of Crizlieva 250mg Tablets. Utilizing a fully compliant, professional pharmaceutical logistics framework, we manage efficient, high-capacity export operations to deliver premium Crizotinib 250mg directly to hospital networks, specialty clinics, pharmacy chains, and international medicine wholesale groups across the USA, UK, Australia, and South Africa.

🔬 Product Profile: Crizlieva 250mg Tablet

Crizlieva 250mg contains Crizotinib, an oral receptor tyrosine kinase inhibitor (TKI) acting as a cutting-edge selective multi-kinase inhibitor. It selectively inhibits the Anaplastic Lymphoma Kinase (ALK) receptor tyrosine kinase, its oncogenic variants (such as ALK fusion proteins), and the ROS1 receptor tyrosine kinase. By effectively blocking these internal molecular pathways, it selectively shuts down downstream cell signaling cascades responsible for tumor cell survival, cellular proliferation, and microvascular metastasis.

• Active Ingredient: Crizotinib (250mg)

• Therapeutic Class: Antineoplastic / Selective Receptor Tyrosine Kinase Inhibitor (TKI)

• Primary Indications:

  • ALK-Positive Metastatic NSCLC: Indicated as a principal therapy for patients presenting with metastatic non-small cell lung cancer whose tumors test positive for abnormal anaplastic lymphoma kinase (ALK) genetic anomalies.

  • ROS1-Positive Metastatic NSCLC: Extensively deployed for the systemic clinical management of patients with metastatic non-small cell lung cancer characterized by explicit ROS1 oncogenic alterations.

📦 Logistics & Sourcing Capabilities

• Compliant Supply Lines: Sourced directly through strictly validated pharmaceutical channels operating in total alignment with international GMP compliance protocols.

• Streamlined Global Export: Specialized logistics pathways custom-engineered to seamlessly manage strict customs entry protocols, documentation, and regulatory clearances inside the USA, UK, Australia, and South Africa.

• Institutional Sourcing Power: Fully capable of supporting consistent, high-volume contract wholesale fulfillments for healthcare ministries, clinical groups, and international pharmaceutical networks.

• B2B Documentation Suite: Delivery of full documentation portfolios including validated Certificates of Analysis (COA), export invoices, and batch traceability sheets.

PRESCRIPTION MEDICINE IS  :YES

⚠️ Disclaimer  :Crizlieva 250mg Tablet is a high-potency, targeted prescription antineoplastic medication. It must be administered strictly under the direct guidance, prescription, and supervision of a registered medical oncologist or specialized healthcare physician. The information listed here is compiled exclusively for B2B procurement, wholesale trade, and international pharmaceutical distribution networks; it does not serve as a substitute for professional clinical medical advice.